MBOT - ステムセルズ (Microbot Medical Inc. ) ステムセルズ



symbol MBOT
会社名 Microbot Medical Inc (ステムセルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 マイクロボット・メディカル(Microbot Medical Inc)(旧名:StemCells Inc.)は医療機器会社である。同社は人体内の人工・自然管腔を利用する変換マイクロ・ロボット医療技術の研究・設計・開発・商業化に従事する。同社は自己洗浄シャント(SCS)及びチップキャット(TipCAT)という2つの候補製品の開発に従事する。SCSは水頭症及び正常圧水頭症(NPH)の治療に使用される。チップキャットは大腸内視鏡検査治療用の自走式・セミディスポーザブル内視鏡である。同社のViRob技術は遠隔的または体内に制御される自律運動型マイクロ・ロボットである。マイクロボットSCSデバイスは脳脊髄液(CSF)シャント・システムの脳室内カテーテル部として設計されるロボット・システムである。同社のチップキャットは結腸・血管・尿路を含む人体内の尿細管内腔における診察・治療能力を提供する内視鏡である。   ステムセルズは米国のバイオテクノロジ―会社。幹細胞治療薬や関連ツ―ルと技術の研究、開発、商業化に従事。ヒトやマウスのiPS細胞やES細胞を神経細胞へ効率的に分化できる培地や、培地添加剤、幹細胞表面抗原検出用抗体などを手掛けるほか、ダメ―ジを受けたり失われたりした神経組織などの組織修復及び再生を目指す胞培養製品も提供。   Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
本社所在地 25 Recreation Park Drive Unit 108 Hingham MA 02043 USA
代表者氏名 Harel Gadot ハレル・ガドー
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 908-938-5561
設立年月日 32356
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 7人
url www.microbotmedical.com
nasdaq_url https://www.nasdaq.com/symbol/mbot
EBITDA EBITDA(百万ドル) -6.14700
終値(lastsale) 6.4213
時価総額(marketcap) 1247742.0669
時価総額 時価総額(百万ドル) 15.88509
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 7.86509
当期純利益 当期純利益(百万ドル) -6.13600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Microbot Medical Inc revenues was not reported. Net loss decreased 30% to $3.4M. Basic Earnings per Share excluding Extraordinary Items increased from -$1.95 to -$1.19.



   The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares  2019/12/26 12:55:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 24.) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) DURECT Corporation (NASDAQ: DRRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Exagen Inc (NASDAQ: XGN ) Forty Seven Inc (NASDAQ: FTSV ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Harpoon Therapeutics Inc (NASDAQ: HARP ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) (JPMorgan initiated coverage with an Outperform rating) Microbot Medical Inc (NASDAQ: MBOT ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc.
   Will Microbot Medical’s Robotic Surgery System Be a Big Hit?  2019/12/24 15:05:46 24/7 Wall street
   Nike : Thinking about buying stock in Boeing, Nike, Microbot Medical, Facebook, or Canopy Growth Corp? | MarketScreener  2019/12/24 14:32:02 MarketScreener
NEW YORK, Dec. 24, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BA, NKE, MBOT, FB, and CGC. To see how InvestorsObserver's proprietary scoring system rates these… | December 24, 2019
   MBOT To Unveil 1st Disposable Robot For Endovascular Procedures, Stock Up 77%  2019/12/24 01:04:00 RTT News
Shares of medical device company Microbot Medical Inc. (MBOT) jumped more than 70% on Monday after the Company announced that it would be unveiling LIBERTY, the world's first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures, on January 13, 2020, in San Francisco.
   Microbot Medical Unveils World’s First Fully Disposable Robot for Endovascular Procedures  2019/12/23 15:38:46 Investing News Network
Microbot Medical revealed LIBERTY, the world’s first fully disposable robotic system for use in neurovascular and cardiovascular procedures. The post Microbot Medical Unveils World’s First Fully Disposable Robot for Endovascular Procedures appeared first on Investing News Network .

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ステムセルズ MBOT Microbot Medical Inc. )

 twitter  (公式ツイッターやCEOツイッターなど)